SARS-CoV-2-mediated inflammatory response in lungs: should we look at RAGE?

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.3K citations · Full text

Virus Epidemiology, Novel Coronavirus, Covid-19 Pandemic +8

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Markus Hoffmann, Hannah Kleine‐Weber, Simon Schroeder et al. · Cell · 2020 · 21.1K citations · Full text

Medicine, Viral Pathogenesis, Immunology +8

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges

Chih‐Cheng Lai, Tzu-Ping Shih, Wen‐Chien Ko et al. · International Journal of Antimicrobial Agents · 2020 · 6.3K citations · Full text

Coronavirus Disease-2019, Virus Epidemiology, Respiratory Diseases +8

Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19

Peng Zhang, Lihua Zhu, Jingjing Cai et al. · Circulation Research · 2020 · 1.2K citations · Full text

Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB

Angelika Bierhaus, Stephan Schiekofer, Markus Schwaninger et al. · Diabetes · 2001 · 815 citations